OCHSNER CLINIC FOUNDATION
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $54.4M
- Transactions
- 8,007
- Companies
- 40
- Average per transaction
- $6,791
Who reported the payments
| Pfizer | $10,628,089 |
| Gilead | $6,306,600 |
| Merck | $3,779,651 |
| Abbott | $1,976,343 |
| AbbVie | $1,740,542 |
| Novartis | $1,635,405 |
| Boston Scientific | $1,631,602 |
| Genentech, Inc. | $1,581,451 |
| Edwards Lifesciences | $1,194,361 |
| Alnylam Pharmaceuticals Inc. | $1,192,182 |
| Jazz Pharmaceuticals Inc. | $1,109,905 |
| E.r. Squibb & Sons, L.L.C. | $855,866 |
| T2 Biosystems, Inc. | $849,770 |
| AstraZeneca | $827,592 |
| Beigene, Ltd. | $812,223 |
| Hoffmann-la Roche Limited | $797,551 |
| Medtronic | $783,951 |
| Janssen Research & Development, LLC | $764,921 |
| Nevro Corp. | $586,110 |
| Takeda Pharmaceuticals U.S.A., Inc. | $540,964 |
| Intuitive Surgical | $475,836 |
| Biogen | $460,581 |
| Roche Products Limited | $454,724 |
| Sanofi | $408,944 |
| Eli Lilly | $361,405 |
| Eisai Inc. | $357,553 |
| Genentech USA, Inc. | $351,250 |
| Tesaro, Inc. | $323,582 |
| Cardinal Health 414 LLC | $311,617 |
| Intercept Pharmaceuticals, Inc. | $282,501 |
| Biotissue Holdings Inc. | $281,053 |
| Incyte Corporation | $270,671 |
| C. R. Bard, Inc. & Subsidiaries | $265,891 |
| Neurocrine Biosciences, Inc. | $258,339 |
| Avanos Medical | $235,522 |
| Abiomed | $221,944 |
| UCB SA | $216,025 |
| Vertex | $211,937 |
| Johnson & Johnson | $199,939 |
| Bracco Diagnostics Inc. | $188,530 |